Benchmark Downgrades AbCellera Biologics (ABCL) to Hold

November 6, 2023 9:33 AM EST Send to a Friend
Benchmark analyst Robert Wasserman downgraded AbCellera Biologics (NASDAQ: ABCL) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login